Evidence map›Paper›PMID 35465046›Full record

ArticleThe Lancet regional health. Western Pacific2022

Multi-site implementation of whole genome sequencing for hospital infection control: A prospective genomic epidemiological analysis.

Norelle L Sherry, Claire L Gorrie, Jason C Kwong, Charlie Higgs, Rhonda L Stuart, Caroline Marshall, Susan A Ballard, Michelle Sait, Tony M Korman, Monica A Slavin and 9 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet regional health. Western Pacific, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Investigating pathways of vancomycin-resistantmedRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Infection and immunity · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Norelle L SherryMicrobiological Diagnostic Unit (MDU) Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Claire L GorrieMicrobiological Diagnostic Unit (MDU) Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Jason C KwongDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
Charlie HiggsDepartment of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Rhonda L StuartMonash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
Caroline MarshallInfection Prevention & Surveillance, Victorian Infectious Diseases Service, Melbourne Health, Parkville, Victoria, Australia.
Susan A BallardMicrobiological Diagnostic Unit (MDU) Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Michelle SaitMicrobiological Diagnostic Unit (MDU) Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Tony M KormanMonash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
Monica A SlavinDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
Robyn S LeeDepartment of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Maryza GrahamMonash Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
Marcel LeroiDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
Leon J WorthDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
Hiu Tat ChanDepartment of Microbiology, Melbourne Health, Parkville, Victoria, Australia.
Torsten SeemannMicrobiological Diagnostic Unit (MDU) Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
M Lindsay GraysonDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.
Benjamin P HowdenMicrobiological Diagnostic Unit (MDU) Public Health Laboratory, Department of Microbiology & Immunology at the Peter Doherty Institute for Infection & Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Controlling Superbugs Study Group
The University of Melbourne · AUMonash Health · AUMelbourne Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Current microbiological methods lack the resolution to accurately identify multidrug-resistant organism (MDRO) transmission, however, whole genome sequencing can identify highly-related patient isolates providing opportunities for precision infection control interventions. We investigated the feasibility and potential impact of a prospective multi-centre genomics workflow for hospital infection control. Methods: We conducted a prospective genomics implementation study across eight Australian hospitals over 15 months (2017,2018), collecting all clinical and screening isolates from inpatients with Findings: In total, 2275 isolates were included from 1970 patients, predominantly ESBL-Ec (40·8%) followed by MRSA (35·6%), Interpretation: Implementation of a multi-centre genomics-informed infection control workflow is feasible and identifies many unrecognised MDRO transmissions. This provides critical opportunities for interventions to improve patient safety in hospitals. Funding: Melbourne Genomics Health Alliance (supported by State Government of Victoria, Australia), and National Health and Medical Research Council (Australia).

Indexed as

Antimicrobial resistanceESBL-Ec, Extended-spectrum beta-lactamase Escherichia coliESBL-Kp, Extended-spectrum beta-lactamase Klebsiella pneumoniaeHospital epidemiologyInfection prevention and controlMDRO, Multidrug-resistant organismMRSA, Methicillin-resistant Staphylococcus aureusVRE, Vancomycin-resistant EnterococcusWGS, Whole genome sequencingWhole genome sequencing

Identifiers

PMID35465046
PMCPMC9019234
OpenAlexW4225874552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.